When a solution becomes a problem: doctors and lawmakers on opiate painkillers
Today an FDA advisory panel meets with lawmakers to hammer out voluntary best practices for doctors who prescribe opiates. The regulation of opioid drugs like Oxycontin has loosened in recent years, as patient advocates asked for powerful narcotic painkillers for end-of-life care and cancer treatments. But in loosening restrictions for such cases, the FDA opened a window for wider prescriptions ? and for abuse.
In 2007, according to the FDA, 5.2 million people reported using powerful prescription drugs for nonmedical use. Even those who need the drugs can often develop destructive dependencies.
Even as the FDA works on voluntary guidelines, Washington State is looking to create more powerful binding regulations. As Barry Meier reports in today’s New York Times, doctors will likely be looking at Washington State for a national model. Meier joins The Takeaway, along with Joel Saper, director of the Michigan Head Pain and Neurological Institute and author of an upcoming paper offering expert recommendations on the use of opioids for headaches.
The story you just read is available to read for free because thousands of listeners and readers like you generously support our nonprofit newsroom. Every day, the reporters and producers at The World are hard at work bringing you human-centered news from across the globe. But we can’t do it without you: We need your support to ensure we can continue this work for another year.
When you make a gift of $10 or more a month, we’ll invite you to a virtual behind-the-scenes tour of our newsroom to thank you for being with The World.